TY  - JOUR
AU  - Popping, Stephanie
AU  - Cento, Valeria
AU  - Seguin-Devaux, Carole
AU  - Boucher, Charles A B
AU  - de Salazar, Adolfo
AU  - Heger, Eva
AU  - Mor, Orna
AU  - Sayan, Murat
AU  - Salmon-Ceron, Dominique
AU  - Weis, Nina
AU  - Krarup, Henrik B
AU  - de Knegt, Robert J
AU  - Săndulescu, Oana
AU  - Chulanov, Vladimir
AU  - van de Vijver, David A M C
AU  - García, Federico
AU  - Ceccherini-Silberstein, Francesca
PY  - 2021
DO  - 10.3390/v14010016
UR  - http://hdl.handle.net/10668/21598
T2  - Viruses
AB  - Background: Approximately 71 million people are still in need of direct-acting antiviral agents (DAAs). To achieve the World Health Organization Hepatitis C elimination goals, insight into the prevalence and influence of resistance associated...
LA  - en
PB  - MDPI AG
KW  - direct-acting antivirals
KW  - elimination
KW  - hepatitis C
KW  - resistance
KW  - resistance associated substitutions
KW  - Antiviral Agents
KW  - Drug Resistance, Viral
KW  - Drug Therapy, Combination
KW  - Europe
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - Hepatitis C
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - RNA-Dependent RNA Polymerase
KW  - Retreatment
KW  - Sustained Virologic Response
KW  - Treatment Failure
KW  - Viral Nonstructural Proteins
TI  - The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral Failures.
TY  - research article
VL  - 14
ER  -